FDA approves new drug to treat Alzheimer’s disease

WTVM M-F 11-11:30 Syncbak
Published: Jun. 8, 2021 at 12:15 AM EDT
Email This Link
Share on Pinterest
Share on LinkedIn

COLUMBUS, Ga. (WTVM) - The Food and Drug Administration approved a new, experimental drug to treat Alzheimer’s disease.

Biogen’s medication is called Aducanumab and it’s for mild cognitive impairment associated with the early stages of the brain wasting disease.

Some non-profits didn’t think the medication should be approved, though, the Alzheimer’s Association supported it.

It will take several months for the drug to become available for most patients. Dr. Jonathan Liss at the Columbus Memory Center spoke about the historic day.

“It’s very exciting to get the FDA’s provisional approval today this is a major moment in history. Everybody should always weigh the value of the medication verses the side effects that they may have in this case the Columbus Memory Center has been a world leader in Alzheimer’s research,” said Dr. Liss.

Dr. Liss says Columbus Memory Center could even be the first to have to have the drug.

Columbus Memory Center has worked with Biogen for the past several months to be ready. They could possibly be the first center in the world to do the first infusion.

The drug reportedly is not for people with severe Alzeheimer’s but may be used to help offset early onset Alzeheimer’s symptoms.

Copyright 2021 WTVM. All rights reserved.